Successful direct-acting antiviral therapy in HIV/HCV co-infected patients fails to restore circulating mucosal-associated invariant T cells

Eur J Immunol. 2019 Jul;49(7):1127-1129. doi: 10.1002/eji.201948152. Epub 2019 May 14.
No abstract available

Keywords: DAA; HCV infection; HIV infection; Mucosal-Associated Invariant T-cells (MAIT).

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antiretroviral Therapy, Highly Active / methods*
  • Cell Self Renewal
  • Cohort Studies
  • Coinfection
  • Female
  • HIV Infections / drug therapy*
  • HIV Infections / immunology
  • HIV-1 / physiology*
  • Hepacivirus / physiology*
  • Hepatitis C / drug therapy*
  • Hepatitis C / immunology
  • Humans
  • Immunotherapy / methods*
  • Male
  • Middle Aged
  • Mucosal-Associated Invariant T Cells / physiology*
  • Treatment Outcome
  • Viral Load / drug effects